LeMaitre Vascular Gross Margin 2012-2026 | LMAT
Current and historical gross margin for LeMaitre Vascular (LMAT) over the last 10 years. The current gross profit margin for LeMaitre Vascular as of June 30, 2026 is %.
| LeMaitre Vascular Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $0.26B | $0.19B | 72.90% |
| 2026-03-31 | $0.26B | $0.19B | 72.27% |
| 2025-12-31 | $0.25B | $0.18B | 71.49% |
| 2025-09-30 | $0.24B | $0.17B | 70.95% |
| 2025-06-30 | $0.24B | $0.16B | 68.94% |
| 2025-03-31 | $0.23B | $0.16B | 68.28% |
| 2024-12-31 | $0.22B | $0.15B | 68.64% |
| 2024-09-30 | $0.21B | $0.15B | 68.08% |
| 2024-06-30 | $0.21B | $0.14B | 67.80% |
| 2024-03-31 | $0.20B | $0.13B | 66.83% |
| 2023-12-31 | $0.19B | $0.13B | 65.80% |
| 2023-09-30 | $0.19B | $0.12B | 64.86% |
| 2023-06-30 | $0.18B | $0.11B | 64.41% |
| 2023-03-31 | $0.17B | $0.11B | 65.09% |
| 2022-12-31 | $0.16B | $0.11B | 64.81% |
| 2022-09-30 | $0.16B | $0.11B | 65.22% |
| 2022-06-30 | $0.16B | $0.11B | 65.63% |
| 2022-03-31 | $0.16B | $0.10B | 65.41% |
| 2021-12-31 | $0.16B | $0.10B | 65.81% |
| 2021-09-30 | $0.15B | $0.10B | 65.36% |
| 2021-06-30 | $0.15B | $0.10B | 64.90% |
| 2021-03-31 | $0.14B | $0.09B | 65.19% |
| 2020-12-31 | $0.13B | $0.08B | 64.62% |
| 2020-09-30 | $0.12B | $0.08B | 65.57% |
| 2020-06-30 | $0.12B | $0.08B | 66.96% |
| 2020-03-31 | $0.12B | $0.08B | 67.23% |
| 2019-12-31 | $0.12B | $0.08B | 68.10% |
| 2019-09-30 | $0.11B | $0.08B | 68.42% |
| 2019-06-30 | $0.11B | $0.08B | 68.81% |
| 2019-03-31 | $0.11B | $0.07B | 69.16% |
| 2018-12-31 | $0.11B | $0.07B | 69.52% |
| 2018-09-30 | $0.10B | $0.07B | 69.90% |
| 2018-06-30 | $0.10B | $0.07B | 70.19% |
| 2018-03-31 | $0.10B | $0.07B | 69.90% |
| 2017-12-31 | $0.10B | $0.07B | 70.30% |
| 2017-09-30 | $0.10B | $0.07B | 70.41% |
| 2017-06-30 | $0.10B | $0.07B | 70.83% |
| 2017-03-31 | $0.09B | $0.07B | 70.65% |
| 2016-12-31 | $0.09B | $0.06B | 70.45% |
| 2016-09-30 | $0.09B | $0.06B | 70.59% |
| 2016-06-30 | $0.08B | $0.06B | 70.37% |
| 2016-03-31 | $0.08B | $0.06B | 69.62% |
| 2015-12-31 | $0.08B | $0.05B | 69.23% |
| 2015-09-30 | $0.08B | $0.05B | 68.83% |
| 2015-06-30 | $0.08B | $0.05B | 67.11% |
| 2015-03-31 | $0.07B | $0.05B | 67.57% |
| 2014-12-31 | $0.07B | $0.05B | 66.67% |
| 2014-09-30 | $0.07B | $0.05B | 66.20% |
| 2014-06-30 | $0.07B | $0.05B | 67.65% |
| 2014-03-31 | $0.07B | $0.05B | 68.18% |
| 2013-12-31 | $0.06B | $0.05B | 70.31% |
| 2013-09-30 | $0.06B | $0.04B | 70.49% |
| 2013-06-30 | $0.06B | $0.04B | 70.00% |
| 2013-03-31 | $0.06B | $0.04B | 72.41% |
| 2012-12-31 | $0.06B | $0.04B | 71.93% |
| 2012-09-30 | $0.06B | $0.04B | 74.55% |
| 2012-06-30 | $0.06B | $0.04B | 73.21% |
| 2012-03-31 | $0.06B | $0.04B | 70.18% |
| 2011-12-31 | $0.06B | $0.04B | 68.97% |
| 2011-09-30 | $0.06B | $0.04B | 67.80% |
| 2011-06-30 | $0.06B | $0.04B | 68.97% |
| 2011-03-31 | $0.06B | $0.04B | 71.93% |
| 2010-12-31 | $0.06B | $0.04B | 73.21% |
| 2010-09-30 | $0.06B | $0.04B | 73.21% |
| 2010-06-30 | $0.06B | $0.04B | 74.55% |
| 2010-03-31 | $0.05B | $0.04B | 72.22% |
| 2009-12-31 | $0.05B | $0.04B | 72.55% |
| 2009-09-30 | $0.05B | $0.04B | 71.43% |
| 2009-06-30 | $0.05B | $0.03B | 68.75% |
| 2009-03-31 | $0.05B | $0.03B | 68.75% |
| 2008-12-31 | $0.05B | $0.03B | 67.35% |
| 2008-09-30 | $0.05B | $0.03B | 68.75% |
| 2008-06-30 | $0.05B | $0.03B | 71.74% |
| 2008-03-31 | $0.04B | $0.03B | 74.42% |
| 2007-12-31 | $0.04B | $0.03B | 75.61% |
| 2007-06-30 | $0.03B | $0.02B | 82.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.847B | $0.250B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |